Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome
Authors:
Open Access
- 8 December 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (69) , 113957-113965
Abstract
Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndromeKeywords
This publication has 36 references indexed in Scilit:
- Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFαGut, 2012
- Irritable Bowel Syndrome: A Review and UpdateClinics in Colon and Rectal Surgery, 2012
- Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndromeGut Pathogens, 2010
- Irritable bowel syndrome immune hypothesis: Part two: the role of cytokinesRevista Española de Enfermedades Digestivas, 2010
- Intracellular Toll-like ReceptorsImmunity, 2010
- Association of symptoms with gastrointestinal microbiota in irritable bowel syndromeWorld Journal of Gastroenterology, 2010
- From endoplasmic-reticulum stress to the inflammatory responseNature, 2008
- Guidelines on the irritable bowel syndrome: mechanisms and practical managementGut, 2007
- Immune Activation in Patients With Irritable Bowel SyndromeGastroenterology, 2007
- Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCRJournal of Applied Microbiology, 2004